share_log

D: Filing D

D: Filing D

D：发行公告
美股SEC公告 ·  07/26 16:10
Moomoo AI 已提取核心信息
SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.
SeaStar Medical Holding Corp has filed a Form D Notice of Exempt Offering of Securities with the SEC, indicating a new notice for an offering of securities. The filing, dated July 26, 2024, reports that the company, incorporated in Colorado in 2020, has successfully sold $10 million worth of securities, including common stock and equivalents, as well as warrants. The offering was made under Rule 506(b) and did not involve a business combination transaction. SeaStar Medical did not disclose the issuer size and declined to provide the revenue or aggregate net asset value. The company has paid approximately $850,000 in placement agent fees and expenses related to the offering. The proceeds from the offering will not be used for payments to any executive officers, directors, or promoters. The company's executive team, including CEO Eric Schlorff and CFO David Green, along with other directors, are named in the filing. The securities offered are classified under the 'Other Health Care' industry group.
SeaStar Medical Holding Corp已向SEC提交了Form D豁免证券通知，表示推出一项证券发行的新公告。文件显示，该公司于2020年在科罗拉多州成立，已成功销售价值1000万美元的证券，包括普通股和等值股份，以及认股权证。此次发行是根据规则506(b)进行的，没有涉及业务组合交易。SeaStar Medical未披露发行商大小，并拒绝提供营业收入或总净资产价值。该公司支付了约85万美元的放置代理费用和与发行相关的费用。发行所得将不用于向任何高管、董事或发起人支付款项。文件中提及了该公司的执行团队，包括CEO Eric Schlorff、CFO David Green以及其他董事。所提供的证券归类于“其他医疗保健”行业板块。
SeaStar Medical Holding Corp已向SEC提交了Form D豁免证券通知，表示推出一项证券发行的新公告。文件显示，该公司于2020年在科罗拉多州成立，已成功销售价值1000万美元的证券，包括普通股和等值股份，以及认股权证。此次发行是根据规则506(b)进行的，没有涉及业务组合交易。SeaStar Medical未披露发行商大小，并拒绝提供营业收入或总净资产价值。该公司支付了约85万美元的放置代理费用和与发行相关的费用。发行所得将不用于向任何高管、董事或发起人支付款项。文件中提及了该公司的执行团队，包括CEO Eric Schlorff、CFO David Green以及其他董事。所提供的证券归类于“其他医疗保健”行业板块。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息